First-Ever Treatment for Rare Rapid-Aging Disease Progeria Receives U.S. FDA Approval

PEABODY, Mass., Nov. 20, 2020 /PRNewswire/ -- The Progeria Research Foundation (PRF) today announced a historic milestone with the U.S. Food and Drug Administration (FDA) approval of Zokinvy™ (lonafarnib), for the treatment of Progeria and processing-deficient Progeroid Laminopathies (PL)....

from PR Newswire: https://ift.tt/331Qvro